Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2002
08/01/2002CA2431904A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
08/01/2002CA2429490A1 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation
07/2002
07/31/2002EP1226146A2 Quinoline and naphthyridine carboxylic acid antibacterials
07/31/2002EP1226143A2 Imidazopyridine derivatives used as phosphodiesterase vii inhibitors
07/31/2002EP1226138A1 Fab i inhibitors
07/31/2002EP1226127A2 Uracil substituted phenyl sulfamoyl carboxamides
07/31/2002EP1226119A2 Tyrosine kinase inhibitors
07/31/2002EP0833837B1 Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide
07/31/2002CN1361783A Thiazoloderivatives and pharmaceutical compositions containing them
07/31/2002CN1361779A New compounds
07/31/2002CN1361768A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
07/31/2002CN1088359C Medicine for curing cerebrovascular disturbance with psychonosema
07/30/2002US6426417 Processes and intermediates useful to make antifolates
07/30/2002US6426415 Polyadenosine 5'-diphospho-ribose polymerase (parp) enzyme inhibitors, alkoxy substituted n-heterocycle derivatives
07/30/2002US6426353 α v integrin receptor antagonists
07/30/2002US6426345 Phosphodiesterase inhibitors; antiinflammatory agents
07/30/2002CA2103554C Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as contrast agents
07/30/2002CA2078039C Process for the production of lactams
07/25/2002WO2002057265A1 Compounds substituted with bicyclic amino groups
07/25/2002WO2002057264A1 Pyrrole derivates for treating cytokine mediated diseases
07/25/2002WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors
07/25/2002WO2002057254A1 Compositions for prevention or treatment of hepatopathy
07/25/2002WO2002057242A2 Urea derivatives as integrin alpha 4 antagonists
07/25/2002WO2002057236A1 Phenyl derivatives
07/25/2002WO2002056882A1 Quinolines and nitrogenated derivaive thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
07/25/2002WO2002050061A8 Piperazine derivatives for treatment of bacterial infections
07/25/2002WO2002032901A3 Bridged piperazine derivatives
07/25/2002WO2002032422A3 Ep4 receptor inhibitors to treat rheumatoid arthritis
07/25/2002WO2002018379A3 7-oxo pyridopyrimidines
07/25/2002WO2002017918A3 Sustained release formulations for growth hormone secretagogues
07/25/2002WO2002014320A3 Novel substituted diaryl azepine derivatives as integrin ligands
07/25/2002WO2002002519A3 THROMBIN OR FACTOR Xa INHIBITORS
07/25/2002WO2002000653A3 Fused cyclic compounds as modulators of nuclear hormone receptor function
07/25/2002US20020099212 Sulfonamide compounds and pharmaceutical use thereof
07/25/2002US20020099208 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
07/25/2002US20020099184 Radiolabeled compounds useful as imaging agents for visualizing the location and density of serotonin transporter by tomography imaging; as diagnostic and therapeutic agents for diseases associated with serotonin transporter dysfunction
07/25/2002US20020099074 Novel anilide compounds and drugs containing the same
07/25/2002US20020099072 Anti-hepatitis or anti-herpes
07/25/2002US20020099071 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
07/25/2002US20020099070 Dihydronaphthyridine potassium channel openers
07/25/2002US20020099069 Central nervous system (CNS); bridged nicotine analogs of N-octylnicotinium iodide (NONI) having selective antagonist properties at alpha 3 beta 2-containing nicotinic receptor subtypes
07/25/2002US20020099068 I kappa B kinase inhibitors for treating various disorders including arthritis
07/25/2002US20020099066 Antitumour 1,5-diazaanthraquinones
07/25/2002US20020099065 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
07/25/2002US20020099054 2-phenyl benzimidazole derivatives as MCP-1 antagonists
07/25/2002US20020099030 Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic properties
07/25/2002US20020098242 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
07/25/2002DE10102322A1 New disubstituted and trisubstituted benzene derivatives useful as coagulation inhibitors for the treatment of thromboembolic diseases
07/25/2002CA2435692A1 Pyrrole derivates for treating cytokine mediated diseases
07/25/2002CA2435141A1 Compositions for prevention or treatment of hepatopathy
07/25/2002CA2434939A1 Urea derivatives as integrin alpha 4 antagonists
07/24/2002EP1225174A1 Anhydrous mirtazapine crystals and process for the production thereof
07/24/2002EP1225173A1 Naphthyridine derivatives
07/24/2002EP1224189A2 Condensed dihydroquinolinone derivatives for inhibiting mrp1
07/24/2002EP1224187A2 Certain alkylene diamine-substituted heterocycles
07/24/2002EP1224186A2 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
07/24/2002EP1224185A1 Thiazole and imidazo[4,5-b]pyridine compounds and their pharmaceutical use
07/24/2002EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method
07/24/2002EP1224171A1 Beta disubstituted metalloprotease inhibitors
07/24/2002EP1223938A1 TREATMENT OF MOVEMENT DISORDERS BY ADMINISTRATION OF 5-HYDROXYTRYPTAMINE RECEPTOR/$g(a) 2? ADRENERGIC RECEPTOR ANTAGONIST COMPOSITIONS
07/24/2002EP1223935A1 Methods of use of fluoroquinolone compounds against bacteria
07/24/2002EP0988045A4 Peptide nucleic acid monomers and oligomers
07/24/2002EP0900218B1 Heterocyclic compounds
07/24/2002EP0820454B1 Anellated beta-carbolines
07/24/2002EP0693070B1 PYRIDO[2,3-b](1,4)BENZODIAZEPINONES AS M2 RECEPTOR LIGAND FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
07/24/2002EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors
07/24/2002CN1360588A Hemisynthetic method and intermediate thereof
07/24/2002CN1360580A Substd. benzoyl ketones, methods for producing them and their use as herbicides
07/23/2002US6423845 Cyclization a 2-amino-3-formylpyridine compound; bone disorders, osteoporosis
07/23/2002US6423842 Act preferentially on m4 receptors; side effect reduction; used to treat nervous system disorders, psychological disorders and as an analgesic; alzheimer's disease; cognition activators.
07/23/2002US6423840 Forming n-acylamino compound
07/23/2002US6423716 Nitrogenous heterocyclic compounds
07/23/2002US6423713 Substituted pyrazoles as p38 kinase inhibitors
07/23/2002US6423711 Useful in diagnosis and therapy of anxiety, down syndrome, sleep, cognitive and seizure disorders, and overdose with benzodiazepine drugs and for enhancement of alertness
07/23/2002US6423708 Aralkyl and aralkylidene heterocyclic lactams and imides
07/23/2002CA2102180C Novel immunosuppressive pyrrolidine/piperidine/azepane-2-carboxylic acid derivatives
07/18/2002WO2002055525A1 Retinoid agonists
07/18/2002WO2002055510A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
07/18/2002WO2002055501A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
07/18/2002WO2002055079A2 Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
07/18/2002WO2002042250B1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES
07/18/2002WO2002040455A8 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars)
07/18/2002WO2002024661A3 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
07/18/2002WO2002012224A3 Bicyclic compounds as h3 receptor ligands
07/18/2002WO2002002557A3 2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands
07/18/2002WO2002000623A3 Aryl fused substituted 4-oxy-pyridines
07/18/2002WO2001094345A3 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
07/18/2002WO2001083480A3 Dihydropyridine compounds and methods of use
07/18/2002WO2001045679A3 Use of chemotherapeutic agents for topical treatment
07/18/2002US20020095043 Reducing a nitro-substituted 3-azabicyclo(3.1.0)hexane compound in the presence of iron and an organic solvent under acidic conditions and acylating the product
07/18/2002US20020095038 Novel method for the preparation of piperazine and its derivatives
07/18/2002US20020094992 Administering growth hormone secretagogue which is 2-amino-N-(2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a, 4,6,7-hexahydro-pyrazolo(4,3-c)pyridin-5-yl)1-(R)-benzyloxymet hyl-2-oxo-ethyl)-isobutyramide, salt or prodrug
07/18/2002US20020094989 Pyrrolidine modulators of CCR5 chemokine receptor activity
07/18/2002US20020094978 Novel isoxazoline fibrinogen receptor antagonists
07/18/2002US20020094977 Benzo(3,4)pyrido(3,2-a)cycloctenes and benzo(3,4)pyrido-(3,2-a)oxocins, -thiocins or azocines; anticholesterol, antilipemic agents; lowering LDL cholesterol; increasing HDl cholesterol; hypertriglyceridemia and atherosclerosis
07/18/2002US20020094960 Specifically unipolar depression, treatment-refractory depression, resistant depression, anxious depression and dysthymia; 2-sulfamatomethyltetrahydropyrans and sulfamato-methylcyclohexanes, e.g. topiramate
07/18/2002US20020094936 Fungicidal activity
07/18/2002US20020094935 N-([1,2,4] triazoloazinyl) thiophenesulfonamide compounds and their use as herbicides
07/18/2002CA2434274A1 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
07/18/2002CA2425625A1 Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors